Riskpilot← Back to searchSign inGet full accessHELIMED AS
ASActiveOrg 975856437Kyrres Vei 22B, 1369 StabekkGeneral medical practice activities · NACE 8621Est. 19952 employees
Revenue 2024
NOK 4,1M
-1% vs 2023
EBITDA margin
34.3%
-10% vs 2023
Equity ratio
24.9%
Financial strength
Net profit 2024
NOK 966K
-11% vs 2023
| Revenue | NOK 4,1M | -1% |
| EBITDA | NOK 1,4M | -10% |
| Net profit | NOK 966K | -11% |
| Total assets | NOK 2,2M | -8% |
| Equity | NOK 538K | -1% |
| Employees | 2 | — |
Legal name
HELIMED AS
Org number
975856437
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
1. juli 1995
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Kyrres Vei 22B, 1369 Stabekk
Phone
+4722333151
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 405 | 2 076 | 2 212 | 2 425 | 2 524 | 2 684 | 2 882 | 2 864 | 2 824 | 3 251 | 3 295 | 3 643 | 3 849 | 3 806 | 3 991 | 4 179 | 4 139 |
| Staff expenses | −1 054 | −760 | −1 108 | −1 282 | −1 489 | −1 534 | −1 526 | −1 470 | −1 540 | −1 673 | −1 789 | −1 776 | −1 593 | −1 583 | −1 814 | −1 411 | −1 534 |
| EBITDA | 833 | 343 | 81 | −37 | −153 | −62 | 121 | 84 | −1 | 331 | 111 | 676 | 1 006 | 1 043 | 1 011 | 1 579 | 1 420 |
| Depreciation & amort. | −256 | −325 | −325 | −287 | −134 | −48 | −22 | −134 | −134 | −134 | −96 | −120 | −63 | −176 | −161 | −174 | −169 |
| EBIT | 577 | 18 | −244 | −325 | −287 | −110 | 99 | −49 | −135 | 197 | 15 | 556 | 944 | 867 | 850 | 1 405 | 1 251 |
| Net financials | −35 | −26 | 28 | −8 | 6 | 1 | −4 | −25 | −16 | −11 | −8 | −2 | −1 | 0 | −0 | 0 | −4 |
| Profit before tax | 542 | −8 | −217 | −332 | −281 | −108 | 95 | −75 | −151 | 186 | 7 | 554 | 943 | 867 | 850 | 1 405 | 1 247 |
| Tax | 153 | −35 | −61 | −91 | −79 | −28 | 32 | −21 | −33 | 52 | 41 | 112 | 200 | 193 | 170 | 319 | 282 |
| Net profit | 389 | 27 | −156 | −241 | −202 | −80 | 63 | −54 | −118 | 134 | −34 | 443 | 743 | 674 | 680 | 1 086 | 966 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 634 | 1 485 | 1 169 | 830 | 541 | 450 | 1 028 | 874 | 706 | 754 | 569 | 1 091 | 1 593 | 1 800 | 1 793 | 2 343 | 2 159 |
| Equity | 813 | 840 | 684 | 443 | 240 | 160 | 223 | 169 | 51 | 185 | 151 | 393 | 516 | 541 | 541 | 541 | 538 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 506 | 410 | 309 | 204 | 101 | 0 | 62 | 58 | 53 | 40 | 17 |
| Short-term debt | 295 | 248 | 256 | 330 | 301 | 290 | 299 | 295 | 345 | 365 | 318 | 698 | 1 015 | 1 202 | 1 198 | 1 762 | 1 604 |
| Total debt | 821 | 645 | 486 | 387 | 301 | 290 | 805 | 705 | 655 | 569 | 418 | 698 | 1 077 | 1 260 | 1 252 | 1 801 | 1 621 |
EBITDA margin
34.3%
This company
15.8%
Market median
+117% vs market
20082024
Equity ratio
24.9%
This company
38.2%
Market median
-35% vs market
20082024
Return on equity
179.6%
This company
18.4%
Market median
+876% vs market
20082024
Net profit margin
23.3%
This company
8.1%
Market median
+188% vs market
20082024
Asset turnover
1.92×
This company
1.12×
Market median
+71% vs market
20082024
Debt / equity
3.01×
This company
0.62×
Market median
-385% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AK Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2005 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HELIMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ann Karen Matthew Rygh | Chief Executive Officer | 0 companies |
| Helge Rygh | Chairman | 0 companies |